These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The varying effects of a range of preservatives on Myoviridae and Siphoviridae bacteriophages formulated in a semi-solid cream preparation. Brown TL; Ku H; Mnatzaganian G; Angove M; Petrovski S; Kabwe M; Tucci J Lett Appl Microbiol; 2020 Aug; 71(2):203-209. PubMed ID: 32294268 [TBL] [Abstract][Full Text] [Related]
9. Safety of bacteriophage therapy in severe Staphylococcus aureus infection. Petrovic Fabijan A; Lin RCY; Ho J; Maddocks S; Ben Zakour NL; Iredell JR; Nat Microbiol; 2020 Mar; 5(3):465-472. PubMed ID: 32066959 [TBL] [Abstract][Full Text] [Related]
10. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. Spaiser SJ; Culpepper T; Nieves C; Ukhanova M; Mai V; Percival SS; Christman MC; Langkamp-Henken B J Am Coll Nutr; 2015; 34(6):459-69. PubMed ID: 25909149 [TBL] [Abstract][Full Text] [Related]
11. Delivering phage therapy per os: benefits and barriers. Zelasko S; Gorski A; Dabrowska K Expert Rev Anti Infect Ther; 2017 Feb; 15(2):167-179. PubMed ID: 27885865 [TBL] [Abstract][Full Text] [Related]
12. Healthy human gut phageome. Manrique P; Bolduc B; Walk ST; van der Oost J; de Vos WM; Young MJ Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10400-5. PubMed ID: 27573828 [TBL] [Abstract][Full Text] [Related]
13. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial. Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial. Nakajima A; Seki M; Taniguchi S; Ohta A; Gillberg PG; Mattsson JP; Camilleri M Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):537-547. PubMed ID: 29805116 [TBL] [Abstract][Full Text] [Related]
15. Effects of a wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal health parameters in healthy adult human volunteers: a double-blind, randomised, placebo-controlled, cross-over trial. François IE; Lescroart O; Veraverbeke WS; Marzorati M; Possemiers S; Evenepoel P; Hamer H; Houben E; Windey K; Welling GW; Delcour JA; Courtin CM; Verbeke K; Broekaert WF Br J Nutr; 2012 Dec; 108(12):2229-42. PubMed ID: 22370444 [TBL] [Abstract][Full Text] [Related]